Genmab
Jan Van Veen is a seasoned communications professional with extensive experience across various sectors. Currently serving as Vice President of Communications & Public Affairs at Genmab since August 2019 and as a board member at HollandBIO, Jan has a strong background in corporate affairs from roles at Amgen, where responsibilities included overseeing communications for multiple affiliates in Europe. Previous positions at Océ, Comsent, and Radboud University reflect expertise in internal communications, organizational change, and teaching, supplemented by a Master's degree in Business Communications from Radboud University. Jan's diverse experience also includes consulting for healthcare institutions and managing public relations in various organizational settings.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.